Literature DB >> 1394409

Repeat balloon aortic valvuloplasty.

R Koning1, A Cribier, C Asselin, D Mouton-Schleifer, G Derumeaux, B Letac.   

Abstract

This paper attempts to determine limitations and indications of performing a second balloon aortic valvuloplasty procedure (BAV2) because of restenosis, which is the major limitation of this technique. From September 1985 to December 1989, 357 patients underwent a primary BAV (BAV1) and 67 patients had a BAV2. Forty-two patients (group A) had repeat catheterization because they were markedly symptomatic 11 +/- 7 months after BAV1. Twenty-five patients (group B) came from a group of 73 patients who had been systematically scheduled for repeat catheterization in order to evaluate the hemodynamic restenosis rate 8 +/- 3 months after BAV. At time of BAV2 most of the patients of group A were severely disabled. Comparison of pre-BAV2 gradient and aortic valve area with pre-BAV1 measurements showed in a slightly less severe degree of aortic stenosis in group A and in group B with any difference in cardiac index and ejection fraction. Immediately following BAV2, the gradient decreased from 72 +/- 22 to 33 +/- 15 mm Hg (P less than 0.001) and aortic valve area increased from 0.56 +/- 0.18 to 0.85 +/- 0.28 cm2 (p less than 0.001) in group A. In group B, gradient decreased from 68 +/- 15 to 33 +/- 15 mm Hg (p less than 0.001) and aortic valve area increased from 0.70 +/- 0.16 to 0.90 +/- 0.25 cm2 (p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1394409     DOI: 10.1002/ccd.1810260402

Source DB:  PubMed          Journal:  Cathet Cardiovasc Diagn        ISSN: 0098-6569


  2 in total

Review 1.  Percutaneous balloon aortic valvuloplasty in different age groups.

Authors:  Anna Olasińska-Wiśniewska; Olga Trojnarska; Marek Grygier; Maciej Lesiak; Stefan Grajek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2013-03-21       Impact factor: 1.426

2.  Direct transcatheter aortic valve implantation - one-year outcome of a case control study.

Authors:  Janusz Kochman; Lukasz Kołtowski; Zenon Huczek; Piotr Scisło; Leopold Bakoń; Radosław Wilimski; Bartosz Rymuza; Grzegorz Opolski
Journal:  Postepy Kardiol Interwencyjnej       Date:  2014-11-17       Impact factor: 1.426

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.